var x = 
{%22username%22:%22Gayle_Mayo%22%2C%22start_year%22:2005%2C%22end_year%22:2017%2C%22topics%22:[{%22value%22:%22neurolo%2A%20OR%20neurosurg%2A%20%22%2C%22label%22:%22Neuro%22%2C%22index%22:0%2C%22active%22:false}%2C{%22value%22:%22cardiovas%2A%22%2C%22label%22:%22Cardio%22%2C%22index%22:1%2C%22active%22:false}%2C{%22value%22:%22%28cancer%20NOT_IN%20\%22cancer%20center\%22%29%20%20OR%20oncolog%2A%22%2C%22label%22:%22Cancer%22%2C%22index%22:2%2C%22active%22:false}%2C{%22value%22:%22transplan%2A%20OR%20\%22organ%20preserv%2A\%22%22%2C%22label%22:%22Transplant%22%2C%22index%22:3%2C%22active%22:false}%2C{%22value%22:%22musculoskel%2A%22%2C%22label%22:%22Muscoloskel%22%2C%22index%22:4%2C%22active%22:false}%2C{%22value%22:%22gastro%2A%22%2C%22label%22:%22Gastroent%22%2C%22index%22:5%2C%22active%22:false}]%2C%22researchers%22:[]%2C%22institutions%22:[{%22label%22:%22Mayo%22%2C%22value%22:%22mayo%2A%22%2C%22active%22:true%2C%22index%22:0}%2C{%22label%22:%22UPenn%22%2C%22value%22:%22\%22univ%2A%20of%20penn%2A\%22%22%2C%22active%22:true%2C%22index%22:1}%2C{%22label%22:%22MD%20Anderson%22%2C%22value%22:%22%28\%22md%20anderson\%22%29%20OR%20%28\%22m.d.%20anderson\%22%29%22%2C%22active%22:true%2C%22index%22:2}%2C{%22label%22:%22Johns%20Hopkins%22%2C%22value%22:%22\%22johns%20hopkins\%22%22%2C%22active%22:true%2C%22index%22:3}%2C{%22label%22:%22Partners%20HC%22%2C%22value%22:%22\%22partners%20healthcare\%22%22%2C%22active%22:true%2C%22index%22:4}%2C{%22label%22:%22Harvard%22%2C%22value%22:%22harvard%22%2C%22active%22:true%2C%22index%22:5}%2C{%22label%22:%22MassGen%22%2C%22value%22:%22\%22mass%2A%20general%2A\%22%22%2C%22active%22:true%2C%22index%22:6}%2C{%22label%22:%22Brigham%20and%20Womens%22%2C%22value%22:%22brigham%20AND%20women%2A%22%2C%22active%22:true%2C%22index%22:7}%2C{%22label%22:%22Cleveland%20Clinic%22%2C%22value%22:%22\%22cleveland%20clinic\%22%22%2C%22active%22:true%2C%22index%22:8}%2C{%22label%22:%22UPitt%22%2C%22value%22:%22\%22univ%2A%20of%20pitt%2A\%22%22%2C%22active%22:true%2C%22index%22:9}%2C{%22label%22:%22UCLA%22%2C%22value%22:%22ucla%20OR%20%28\%22univ%2A%20of%20calif%2A%20at%20los%20angeles\%22%29%22%2C%22active%22:true%2C%22index%22:10}%2C{%22label%22:%22NY%20Presb%22%2C%22value%22:%22\%22new%20york%20presbyterian\%22%22%2C%22active%22:true%2C%22index%22:11}%2C{%22label%22:%22Cornell%22%2C%22value%22:%22cornell%22%2C%22active%22:true%2C%22index%22:12}%2C{%22label%22:%22Columbia%22%2C%22value%22:%22Columbia%22%2C%22active%22:true%2C%22index%22:13}%2C{%22label%22:%22Wake%20Forest%22%2C%22value%22:%22\%22wake%20forest\%22%22%2C%22active%22:true%2C%22index%22:14}]%2C%22meshList%22:[]%2C%22docTypes%22:[{%22label%22:%22PATENT%22%2C%22value%22:%22PATENT%22%2C%22active%22:true%2C%22index%22:%220%22}%2C{%22label%22:%22PUBMED%22%2C%22value%22:%22PUBMED%22%2C%22active%22:true%2C%22index%22:%221%22}%2C{%22label%22:%22NIH%22%2C%22value%22:%22NIH%22%2C%22active%22:true%2C%22index%22:%222%22}%2C{%22label%22:%22NSF%22%2C%22value%22:%22NSF%22%2C%22active%22:true%2C%22index%22:%223%22}%2C{%22label%22:%22CLINICAL%20TRIALS%22%2C%22value%22:%22CLINICALTRIALS%22%2C%22active%22:true%2C%22index%22:%224%22}%2C{%22label%22:%22VC%20DATA%22%2C%22value%22:%22TRACXN%22%2C%22active%22:true%2C%22index%22:%225%22}%2C{%22active%22:true%2C%22label%22:%22SBIR%22%2C%22value%22:%22SBIR%22%2C%22index%22:%226%22}]%2C%22mainQuery%22:%22%28%28\%22stem%20cell%2A\%22%20OR%20regenerative%29%20AND%20%28Autologous%20OR%20Allogeneic%20OR%20adult%20OR%20pediatric%20OR%20%28neurolo%2A%20OR%20neurosurg%2A%29%20OR%20%28cardiovas%2A%29%20OR%20%28%28cancer%20NOT_IN%20\%22cancer%20center\%22%29%20OR%20oncolog%2A%29%20OR%20%28transplan%2A%20OR%20\%22organ%20preserv%2A\%22%29%20OR%20%28musculoskel%2A%29%20OR%20%28gastro%2A%29%29%29%20AND%20%28cardiomyocyte%20OR%20%28\%22ES%20cell%20for%20diabetes\%22%29%20OR%20%28%20neocartilage%29%20OR%20%28\%22satellite%20cell%2A\%22%29%20OR%20%28\%22ctx%20neural%20cell%20line\%22%29%20OR%20%28\%22neural%20progenitor\%22%29%20OR%20%28cancer%20AND%20stem%20AND%20cell%29%20OR%20%28\%22wharton%2A%20jelly\%22%29%20OR%20%28%28\%22neurotrophic%20factor\%22%29%20AND%20secreting%29%20OR%20%28\%22antibody%20coupled%20receptor\%22%29%20OR%20%28\%22cancer%20vaccine%2A\%22%29%20OR%20%28\%22autologous%20ixmyelocel%20therapy\%22%29%20OR%20%28\%22neural%20stem%20cell%2A\%22%29%20OR%20%28\%22dendritic%20cell%20vaccine\%22%20AND%20\%22glioblastoma%20lys%2A\%22%29%20OR%20%28\%22msc%2A%20measles%20virus\%22%29%20OR%20%28\%22ovarian%20cancer\%22%29%20OR%20%28\%22msc%2A%20matrix\%22%29%20OR%20%28\%22cardiac%20stem%20cell%2A\%22%29%20OR%20%28\%22cardiosphere%20derived\%22%29%20OR%20%28\%22Cell%20therapy\%22%20OR%20\%22adipose-derived\%22%20OR%20\%22adipose-tissue%20derived%20stem%20cells\%22%20OR%20\%22ADSC\%22%20OR%20\%22transplant\%22%20OR%20\%22bone%20marrow\%22%20OR%20\%22induced%20pluripotent%20stem%20cells\%22%20OR%20\%22IpS\%22%20OR%20\%22progenitor\%22%20OR%20\%22phenotype\%22%20OR%20\%22Th1-Th2%20immune%20response\%22%20OR%20\%22helper%20T%20cell\%22%20OR%20\%22HLA%20matching\%22%20OR%20\%22human%20leukocyte%20antigens\%22%20OR%20\%22immunomodulatory\%22%20OR%20\%22NK%20receptor%20ligands\%22%20OR%20\%22stem%20cell%20transplant\%22%20OR%20\%22bone%20marrow%20transplant\%22%20OR%20\%22fetal-derived\%22%20OR%20\%22embryonic%20stem%20cells\%22%20OR%20\%22cell%20immunotherapy\%22%20OR%20\%22CAR-T%20cell%20therapy\%22%20OR%20\%22allodepleted%20t-cell%20immunotherapy\%22%20OR%20\%22placenta-based%20cell%20therapy\%22%20OR%20\%22directed%20differentiation\%22%20OR%20\%22cord%20lining%20EpSC\%22%20OR%20\%22natural%20killer%20cells\%22%20OR%20\%22stem%20cells\%22%20OR%20\%22systemic%20stem%20cell%20therapy\%22%20OR%20\%22stromal%20vascular%20fraction\%22\%22SVF\%22%20OR%20\%22bone%20marrow%20concentrate\%22%20OR%20\%22bone%20marrow%20mononuclear%20cells\%22%20OR%20\%22umbilical%20cord%20blood\%22%20OR%20\%22cardiopoietic%20stem%20cell%20CP\%22%20OR%20\%22high%20regenerative%20CP\%22%20OR%20\%22endothelial%20progenitor%20cells\%22%20OR%20\%22Hematopoietic%20cells\%22%20OR%20\%22HSCs\%22%20OR%20\%22Mesenchymal%20stromal%20cells\%22%20OR%20\%22MSCs\%22%20OR%20\%22Mesenchymal%20precursor%20cell\%22%20OR%20\%22MPC\%22%20OR%20\%22Chondrocytes\%22%20OR%20\%22T-cells\%22%20OR%20\%22Dermal\%22%20OR%20\%22Fibroblasts\%22%20OR%20\%22Muscle%20cells\%22%20OR%20\%22Pancreatic%20islets\%22%20OR%20\%22Dendritic%20cells\%22%20OR%20\%22Cartilage%20cells\%22%20OR%20\%22tendon%20cell\%22%20OR%20\%22tenocyte\%22%20OR%20\%22tenoblast\%22%20OR%20\%22myocyte\%22%20OR%20\%22skin%20cells\%22%20OR%20\%22oval%20stem%20cells\%22%20OR%20\%22renal%20cells\%22%20OR%20\%22islet%20cells\%22%20OR%20\%22hepatocytes\%22%20OR%20\%22Tumor-Infiltrating%20Lymphocytes\%22%20OR%20\%22TILs\%22%20OR%20\%22Marrow-Infiltrating%20Lymphocytes\%22%20OR%20\%22MILs\%22%29%29%22%2C%22numResearchers%22:0%2C%22numInstitutions%22:0%2C%22numTopics%22:0%2C%22mainFacets%22:[]%2C%22searchName%22:%22test%20new%22%2C%22sessionID%22:%22test%20new%22%2C%22timestamp%22:%2202-08-2017%2018:03:42%22%2C%22instData%22:{%22start_year%22:2000%2C%22end_year%22:2017%2C%22compName%22:%22johns%20hopkins%20university%22}%2C%22vizData%22:{%22start_year%22:2000%2C%22end_year%22:2017}%2C%22repData%22:{%22annot%22:{%22my_rate_text1%22:%22Insights:%20\nOverall%20activity%20%28as%20measured%20by%20total%20market%20signal%20volume%20across%20all%20years%29%20was%20fairly%20stable%20until%202007%20when%20most%20of%20the%20top%20organizations%20experienced%20a%20significant%20uptick%20in%20activity%20followed%20by%20another%20significant%20increase%20in%20activity%20in%202013.%20%20An%20analysis%20of%20activity%20by%20data%20sources%20%28see%20visualization%20page%29%2C%20shows%20the%20surge%20in%202007%20was%20driven%20primarily%20by%20an%20overall%20increase%20in%20NIH%20grants%20around%20this%20topic;%20while%20the%202013%20increase%20is%20driven%20by%20a%20sizable%20increase%20in%20publication%20activity.%20%20\n\nLeaders:%20\nJohns%20Hopkins%2C%20Stanford%20and%20Columbia%20are%20leading%20the%20charge%20in%20this%20area%20with%20Stanford%20accelerating%20away%20from%20the%20pack%20starting%20in%202013.%20Overall%2C%20Mayo%20is%20ranked%2011th%20in%20market%20signal%20activity.%20%20\n\nTop%20Experts:%20%20\nMayo%20has%20the%20largest%20number%20of%20%E2%26%23128%3B%26%23156%3Bexperts%E2%26%23128%3B%9D%20producing%20activity%20in%20the%20cell-based%20arena%20%E2%26%23128%3B%26%23147%3B%20with%2011%20of%20the%20top%2025%20researchers%20by%20market%20signal%20activity%20volume.%20This%20is%20significantly%20more%20than%20any%20other%20organization.%20These%20researchers%20are%20associated%20with%2047%20percent%20of%20activity%20of%20the%20top%2025%20researchers%2C%20%20%28611%20signals%29%2C%20across%20the%20innovation%20pipeline%20for%20cell-based%20activity.%20Top%203%20experts%20in%20cell-based%20activity%20are:%20M%20Gertz%2C%20Mayo%20Clinic;%20A.%20Dispenzieri%2C%20Mayo%20Clinic%2C%20%28both%20in%20hematology%29%2C%20and%20R.%20Champlin%2C%20MD%20Anderson%2C%20%28Chair%2C%20Department%20of%20Department%20of%20Stem%20Cell%20Transplantation%20and%20Cellular%20Therapy%29.%20\n\n%22%2C%22my_accel_text%22:%22Overall%2C%20this%20graphic%20represents%20both%20overall%20activity%20by%20volume%20and%20acceleration%20across%20the%20six%20clinical%20domains.%20%20So%2C%20the%20larger%20the%20circle%2C%20the%20more%20volume%20the%20organization%20has%20in%20the%20clinical%20domain%20being%20represented.%20%20Acceleration%20is%20mapped%20by%20calculating%20the%20most%20recent%203-year%20period%20compared%20to%20the%203%20years%20prior%20and%20is%20plotted%20on%20the%20\%22y\%22%20axis.%20%20So%2C%20any%20bubble%20near%20the%20\%222\%22%20range%20is%20experiencing%20growth%20at%20200%20percent%20and%20anything%20with%20a%20negative%20acceleration%20is%20representative%20of%20recent%20activity%20by%20an%20organization%20that%20did%20not%20previously%20work%20in%20this%20space%20%28so%20they%20did%20not%20have%20the%20prior%203%20years%20worth%20of%20data%20to%20calculate%20acceleration%29.%20%20By%20clicking%20off%20all%20clinical%20domains%20except%20for%20Cancer%20and%20Cardio%2C%20we%20are%20able%20to%20observe%20that%20cancer%20has%20a%20lot%20of%20research%20activity%20in%20terms%20of%20volume%2C%20as%20well%20as%20consistent%20acceleration%20numbers%2C%20in%20the%20100-150%20percent%20range.%20%20Cardio%20is%20far%20smaller%20in%20terms%20of%20volume%2C%20but%20has%20similar%20acceleration%20numbers%20in%20the%2050-120%20percent%20range.%20%20Transplant%20has%20a%20lot%20of%20volume%20%28similar%20to%20Cancer%29%20and%20fairly%20consistent%20acceleration%20numbers%20%28100-200%20percent%29%20compared%20the%20cancer%20domain.%20%20%20%20%20There%20is%20more%20overall%20activity%20in%20Musculoskeletal%20but%20far%20greater%20acceleration%20with%20the%20Gastro%20space%20but%20because%20both%20domains%20are%20still%20relatively%20small%2C%20acceleration%20looks%20more%20significant%20than%20it%20might%20appear%20in%20clinical%20domains%20with%20more%20volume.%20%20%22%2C%22my_vol_topN_text%22:%22The%20table%20below%20highlights%20the%20top%20ranked%20organizations%20overall%20by%20utilizing%20our%20proprietary%20ranking%20algorithm%20%28Super-H%29.%20%20This%20ranking%20algorithm%20takes%20into%20account%20many%20more%20variables%20besides%20volume%20to%20assess%20overall%20activity%20including%2C%20but%20not%20limited%20to%20peak%20year%2C%20funding%2C%20publication%20activity%2C%20etc..%20\n%20Among%20the%20top%2010%20organizations%20represented%20in%20this%20chart%20overall%2C%20five%20of%20them%20were%20NOT%20identified%20as%20peer%20organizations.%20%20This%20finding%20suggests%20that%20Mayo%20may%20not%20have%20the%20most%20accurate%2C%20up-to-date%20view%20of%20the%20market%20today%20and%20they%20may%20be%20missing%20key%20opportunities%20to%20collaborate%20with%20these%20emerging%20competitors%20before%20the%20rest%20of%20the%20industry%20catches%20on.%20%20%20We%20also%20do%20this%20analysis%20across%20the%20six%20clinical%20domains%20and%20are%20able%20to%20identify%20the%20leading%20players%20within%20each%20clinical%20domain%20by%20their%20Super-H%20ranking.%20%20This%20represents%20a%20much%20more%20sophisticated%20ranking%20system%20than%20previously%20deployed%20by%20high%20profile%20industry%20publications%20which%20relied%20primarily%20on%20volume-based%20metrics%20to%20assess%20performance.%20%20%22%2C%22my_bullseye_topN_text%22:%22The%20chart%20depicted%20here%20shows%20the%20volume%20of%20activity%20by%20individual%20organizations%20within%20publications%2C%20grants%2C%20patents%20and%20clinical%20trials%20and%20across%20each%20of%20the%20six%20clinical%20domains.%20%20Both%20the%20Cell-Based%20Cancer%20and%20Transplant%20Clinical%20Domains%20are%20both%20really%20active%20with%20a%20substantial%20amount%20of%20activity%20across%20all%20four%20content%20areas%20with%20grant%20activity%20generating%20the%20highest%20volume%20of%20output.%20%20We%20would%20expect%20that%20more%20By%20comparison%2C%20the%20Musculoskeletal%20and%20Gastroenterology%20Clinical%20Domains%20have%20relatively%20low%20overall%20activity%2C%20both%20within%20organizations%20and%20across%20the%20top%20organizations%20covering%20publications%2C%20patents%2C%20grants%20and%20clinical%20trials.%20%20%20%20Currently%2C%20the%20number%20of%20cell-based%20FDA%20approved%20drugs%20is%20still%20really%20low%20but%20is%20expected%20to%20increase%20significantly%20over%20the%20next%20few%20years%20as%20the%20research%20pipeline%20for%20each%20individual%20research%20organization%20begins%20to%20mature.%20%20%22%2C%22my_table_text%22:%22This%20table%20presents%20a%20SuperH%20rank%20order%20of%20all%20top%20institutions%20%28both%20peer%20and%20top%20N%29%20by%20clinical%20domain%20type.%20%20%20The%20ranking%20algorithm%20takes%20into%20account%20the%20performance%20of%20each%20institution%20within%20the%206%20clinical%20domains%20to%20determine%20ranking%20for%20all%20organizations.%20%20The%20table%20can%20be%20reordered%20by%20each%20column%20to%20provide%20a%20different%20ranking%20for%20each%20of%20the%20institutions.%20%20%20Overall%2C%20Johns%20Hopkins%2C%20Stanford%20and%20MD%20Anderson%20%20are%20top%20ranked%20in%20cell-based%20research%20activities%20across%20all%20clinical%20domains.%20%20%20Subsequent%20rankings%20across%20clinical%20domains%20reveals%20that%20MD%20Anderson%2C%20Stanford%20and%20the%20University%20of%20Michigan%20lead%20in%20the%20Cancer%20domain;%20%20Stanford%2C%20the%20University%20of%20Pittsburgh%20and%20Mayo%20lead%20within%20the%20Cardio%20domain;%20Stanford%2C%20Cornell%20and%20Johns%20Hopkins%20lead%20in%20the%20Gastro%20domain;%20the%20University%20of%20Michigan%2C%20the%20University%20of%20Pittsburgh%20and%20Columbia%20lead%20in%20the%20Musculoskeletal%20domain;%20Stanford%2C%20Mass%20General%20and%20Johns%20Hopkins%20in%20the%20Neuro%20domain%20and%20Stanford%2C%20Johns%20Hopkins%20and%20the%20University%20of%20Minnesota%20in%20the%20Transplant%20domain.%20%20%22%2C%22my_rate_text%22:%22Activity%20vs%20Year%22%2C%22my_rate0-0_text%22:%22Overall%20activity%20%28as%20measured%20by%20total%20volume%20across%20all%20years%29%20in%20the%20Cell-Based%2C%20Neurological%20Clinical%20domain%20is%20characterized%20by%20low%20volume%20even%20though%20there%20is%20increased%20acceleration%20from%20most%20of%20the%20top%20players%20in%20this%20space%20starting%20in%202007.%20%20Interestingly%2C%20the%20University%20of%20California%20at%20San%20Francisco%20and%20Johns%20Hopkins%20experienced%20sharp%20increases%20in%20activity%20beginning%20around%202009%20with%20sustained%20declines%20starting%20again%202011-2012.%20%20Meanwhile%2C%20Stanford%20and%20Mass%20General%20have%20both%20seen%20increased%20activity%20in%20this%20space%20starting%20in%202011.%20%20Mayo%20is%20ranked%2011%20out%20of%2023%20of%20the%20top%20organizations%20in%20the%20Cell-Based%2C%20Neuro%20space.%20%20%22%2C%22my_rate1-0_text%22:%22Overall%20activity%20%28as%20measured%20by%20total%20volume%20across%20all%20years%29in%20the%20Cell-Based%2C%20Cardio%20Clinical%20domain%20is%20characterized%20by%20low%20volume%20even%20though%20there%20is%20increased%20acceleration%20from%20most%20of%20the%20top%20players%20in%20this%20space%20starting%20in%202007.%20%20Starting%202001%20and%202012%2C%20Stanford%2C%20the%20University%20of%20Pittsburgh%20and%20Mayo%20are%20the%20top%20three%20institutions%20in%20this%20space%20with%20Stanford%20accelerating%20away%20from%20the%20pack%20starting%20in%202010.%20%20Further%20analysis%20of%20what%20is%20driving%20Stanford%27s%20activity%20is%20warranted%20as%20the%20increase%20is%20over%20150%%20more%20than%20their%20next%20closest%20competitor.%20%20Mayo%20is%20ranked%203%20of%2023%20of%20the%20top%20organizations%20profiled%20in%20the%20Cell-Based%2C%20Cardio%20space.%20%20%22%2C%22my_rate2-0_text%22:%22Overall%20activity%20%20%28as%20measured%20by%20total%20volume%20across%20all%20years%29%20in%20the%20Cell-Based%2C%20Cancer%20Clinical%20domain%20is%20characterized%20by%20high%20volume%20starting%20in%202000%20with%20significant%20acceleration%20starting%20in%202007.%20%20There%20appears%20to%20be%20significant%20differences%20in%20the%20volume%20of%20activity%20within%20the%20list%20of%20the%20top%20ten%20institutions%20with%20the%20leading%20organizations%20%28MD%20Anderson%2C%20Stanford%2C%20University%20of%20Michigan%20and%20Johns%20Hopkins%29%20having%202-3%20times%20as%20many%20documents%20as%20the%20next%20set%20of%20organizations.%20%20One%20interesting%20note%20is%20that%20Johns%20Hopkins%20did%20experience%20a%20significant%20reduction%20of%20activity%20starting%20in%202009%20through%202014%20suggesting%20that%20further%20analysis%20of%20personnel%20changes%20or%20grant%20reductions%20as%20possible%20reasons%20for%20the%20decline%20are%20warranted.%20%20Mayo%20is%20ranked%208%20of%2023%20the%20leading%20institutions%20in%20Cell-Based%2C%20Cancer%20domain.%20%20%22%2C%22my_rate3-0_text%22:%22Overall%20activity%20%28as%20measured%20by%20total%20volume%20across%20all%20years%29%20in%20the%20Cell-Based%2C%20Transplant%20Clinical%20domain%20is%20characterized%20by%20high%20volume%20starting%20in%202000%20with%20significant%20acceleration%20starting%20in%202007%20%28again%20likely%20due%20to%20the%20NIH%20grant%20funding%20increases%29.%20%20The%20top%20institutions%20in%20this%20space%20include%20the%20usual%20suspects%20of%20Stanford%20and%20Johns%20Hopkins%20with%20the%20University%20of%20Minnesota%20and%20Fred%20Hutchinson%20Cancer%20Research%20Center%20rounding%20out%20the%20top%20four.%20%20There%20is%20less%20dispersion%20among%20the%20top%20institutions%20with%20most%20of%20the%20top%2010%20institutions%20growing%20their%20presence%20in%20this%20space%20over%20the%20last%205%20years%20so%20it%20appears%20to%20be%20super%20competitive%20among%20the%20institutions%20profiled.%20%20Mayo%20is%20listed%20as%20number%2011%20of%2023%20of%20the%20top%20institutions%20ranked%20in%20the%20Cell-Based%2C%20Transplant%20domain.%20%20%22%2C%22my_rate4-0_text%22:%22Overall%20activity%20%28as%20measured%20by%20total%20volume%20across%20all%20years%29%20in%20the%20Cell-Based%2C%20Musculoskeletal%20Clinical%20domain%20is%20characterized%20by%20extremely%20low%20volume%20starting%20in%202000%20and%20little%20overall%20acceleration%20among%20all%20of%20the%20major%20players.%20%20Only%20the%20University%20of%20Michigan%20stands%20out%20with%20increased%20acceleration%20starting%20in%202013%20but%20with%20such%20low%20volume%20of%20activity%20as%20the%20foundation%2C%20even%20small%20increases%20in%20productive%20output%20can%20present%20with%20huge%20numbers%20in%20the%20acceleration%20area.%20%20%20%20%20In%20the%20Cell-Based%2C%20Musculoskeletal%20space%2C%20Mayo%20is%20listed%20as%20number%204%20of%20the%20top%2023%20institutions%20ranked%20in%20this%20clinical%20domain.%20%20%22%2C%22my_rate5-0_text%22:%22Overall%20activity%20%28as%20measured%20by%20total%20volume%20across%20all%20years%29%20in%20the%20Cell-Based%2C%20Gastroenterology%20domain%20is%20characterized%20by%20extremely%20low%20volume%20starting%20in%202005%20and%20little%20overall%20acceleration%20among%20all%20of%20the%20major%20players.%20Stanford%20stands%20out%20for%20its%20acceleration%20increase%20the%20last%20few%20years%20but%20with%20such%20low%20volume%20of%20activity%20as%20the%20foundation%2C%20even%20small%20increases%20in%20productive%20output%20can%20present%20with%20huge%20numbers%20in%20the%20acceleration%20area.%20%20%20%20%20In%20the%20Cell-Based%2C%20Gastroenterology%20space%2C%20Mayo%20is%20listed%20as%20number%202%20of%20the%20top%2023%20institutions%20ranked%20in%20this%20clinical%20domain.%20%20%22}}%2C%22reportTopN%22:0%2C%22reportControl%22:6}